Intracellular signalling mediating HIV-1 gp120 neurotoxicity.
During the last few years several studies have been undertaken to characterise the role of gp120, the HIV-1 envelope glycoprotein, in the pathogenesis of neurological defects associated with AIDS. However, neurons did not appear to be the main target of the virus, since the widespread neuronal damage is not associated with a productive viral infection in neurons. The current opinion supports the hypothesis that an indirect mechanism exists to explain the neuronal cell death which occurs in patients infected by HIV-1. In particular, several reports suggest that gp120 may be the main candidate as mediator of the neurological deficits during HIV-1 infection and demonstrate that this molecule affects neuronal survival through a direct interaction with non-neuronal cell types such as monocytes, macrophages/microglia and astrocytes.
Scorziello
A
A
Institute of Pharmacology, Medical School, University of Genova, Italy.
Florio
T
T
Bajetto
A
A
Schettini
G
G
D015526:AIDS Dementia Complex / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D017209:Apoptosis; D015699:HIV Envelope Protein gp120 / Q000502:physiology*; D015497:HIV-1 / Q000472:pathogenicity*; D006801:Humans; D009474:Neurons / Q000473:pathology*; D015398:Signal Transduction
D015699:HIV Envelope Protein gp120